MedTrace Logo

Effects of Rehabilitation Combined With a Maintenance Program Compared to Rehabilitation Alone in Post-COVID-19

NCT06124625 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-08-17

No results posted yet for this study

Summary

Infection with SARS-CoV-2 virus leads to persistent symptoms for more than 12 weeks in 15% of cases ("post-COVID syndrome"). Symptoms like fatigue, dyspnoea, limitations in physical performance and activities, head ache, anxiety symptoms, and depression are heterogenous which limit physical health and participation in daily life activities.

In the last years, multidisciplinary rehabilitation programs showed benefits in quality of life and symptom intensity in patients with post-COVID. Therefore, rehabilitation programs are recommended for individuals with Post-COVID by official sites like the German Society of Pulmonology and the European Respiratory Society.

Own first data (published at the ERS conference 2023) revealed that one the one hand, inpatient rehabilitation is effective, however, on the other hand, it is challenging to maintain these effects after completing the program. Therefore, the aim of this study is to sustain these benefits by using a digital maintenance program following the rehabilitation program compared to usual care.

Conditions

  • Post-COVID-19 Syndrome

Interventions

PROCEDURE

Rehabilitation combined to a digital maintenance program

Individuals in this group undergo a 3-week inpatient rehabilitation program followed by a 12-week maintenance program (2 sessions per week à 90 minutes, digital and live). The multimodal programs consist of physiotherapy, training therapy, medical support, cognitive training, education and psychological support.

PROCEDURE

Rehabilitation without maintenance program

Individuals in this group undergo a 3-week inpatient rehabilitation program followed by a 12-week usual care period.

Sponsors & Collaborators

  • Bavarian State Ministry of Health and Care (Funding)

    collaborator UNKNOWN

  • Deutsche Rentenversicherung (German pension insurance)

    collaborator UNKNOWN

  • Betriebskrankenkassen Landesverband Bayern (Bavarian health insurance) (Design)

    collaborator UNKNOWN

  • Schön Klinik Berchtesgadener Land

    lead OTHER

Principal Investigators

  • Andreas R Koczulla, PROF · Schön Klinik Berchtesgadener Land

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06124625 on ClinicalTrials.gov